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Analysis of catechol estrogens (2 & 4 hydroxy-estrone and estradiol)
has proven troublesome by liquid chromatography tandem mass
spectrometry due to their low concentrations, short half-lives and
temperature-labile nature. Derivatization to methyl piperazine ana-
logues has been reported for a panel of 9 estrogens in, “Derivatization
enhances analysis of estrogens and their bioactive metabolites in
humanplasma by liquid chromatography tandemmass spectrometry”
(Denver et al., 2019). Data show alteration of the base catalyst in this
method was required to allow detection of catechol estrogens to low
levels. Data also highlight the challenges faced in chromatographic
separation of isomers and isotopologues, which were partially over-
come by employing an extended column length and reduced oven
temperature. In addition, data analysis displayed signiﬁcant matrix
effects during quantitation inplasma, following solid-phase extraction,
despite efﬁcient recoveries.
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omer@ed.ac.uk (N.Z.M. Homer), Mandy.maclean@strath.ac.uk (M.R. MacLean),
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Here we display data in Table 1, which illustrates the mass spectrometry tuning parameters of
MPPZ-derivatives of catechol estrogens, shown by their exact theoretical and observedmasses. In Table
2, data demonstrating the limit of detection that can be achieved for analytes following derivatization
are given for unextracted standards, alongside observed retention times from chromatographic
interpretation, Fig. 1. Finally, the recoveries of catechol estrogens from plasma following solid-phase
extraction (SPE) are displayed in Table 2, with associated data describing matrix effects.
Catechol estrogens (2 and 4-hydroxy-estrogens) are challenging metabolites to analyze by LC-MS/
MS [2,3]. Common analytical challenges arise due to their unstable nature and short half-lives [4].
Derivatization to 1-(2, 4-dinitrophenyl)-4,4-dimethylpiperazinium (MPPZ) derivatives has been suc-
cessfully applied for analysis of estrone, estradiol, 16-hydroxy and 2 and 4 methoxyestrogens [1]. Here
the successes and pitfalls of applying this approach to analyse catechol estrogens are described. For 2
&4-hydroxyestrogens, MPPZ derivatives were generated with the original protocol [1] but with poor
yield, with insufﬁcient detection upon lowering the concentrations (<500 pg mL1). Comparison of
various derivatization base catalysts (sodium bicarbonate, triethylamine, pyridine, ammonium hy-
droxide and N-diethylaniline) was key in achieving efﬁcient derivatization. Modiﬁcation of the base
catalyst to N-diethylaniline enhanced PPZ derivatization with catechol estrogens, showing 500 in-
crease in peak area response, but this approach caused reduction of signals of the 9 other estrogens (E1,
E2,16-hydroxy and 4 and 2-methoxy-estrogens) within this sex steroid pathway. Combinations of base
catalysts were also tested to create a holistic approach. However, derivatization of the catechol me-
tabolites and additional 9 estrogens were only successful in separate reactions.
Structural identiﬁcation of precursor and product ions for the catechol derivates were achieved by
high resolution MS and multiple reaction monitoring for quantitation established by triple quadrupole
MS, Table 1.
Double derivatives of these compounds were not seen, but isomeric mono-derivatives were
observed, believed due to the possibility of either of the A-ring hydroxyl groups reacting. To achieve the
highest degree of chromatographic resolution of isomers and isotopologues, a C18_PFP (2.1 150mm)
Table 1
Mass spectrometric analysis of MPPZ derivatized catechol estrogens.
Analyte-MPPZ Accurate mass
precursor
ion m/z
Theoretical
product
ion mass
Observed
product ion
mass m/z
Product
ion D
ppm
Collision
energy (V)
Collision
exit cell
potential (V)
De-clustering
potential (V)
2OHE1 565.2662 a251.1269
b58.0656
a251.1276
b58.0651
2.78
8.61
59.0
129.0
10.0
10.0
130.0
130.0
4OHE1 565.2662 a251.1269
b58.0656
a251.1274
b58.0673
0.39
29.27c
59.0
129.0
10.0
10.0
130.0
130.0
2OHE2 567.2819 a251.1269
b281.1249
a251.1274
b281.1252
1.99
1.06
61.0
61.0
22.0
22.0
166.0
166.0
4OHE2 567.2819 a251.1269
b281.1249
a251.1265
b281.1251
1.59
0.71
61.0
61.0
22.0
22.0
166.0
166.0
13C6-4OHE1 571.2864 a251.1269
b58.0656
a251.1268
b58.0661
0.39
1.72
50.0
100.0
15.0
15.0
136.0
136.0
13C6-2OHE2 573.3020 a251.1269
b281.1249
a251.1269
b281.1251
0.00
0.71
50.0
50.0
15.0
15.0
136.0
136.0
aquantiﬁer ion, bqualiﬁer ion, cFragments with low signal intensity following infusion generated higher ppm values; Entrance
potential¼ 10V;mass to charge (m/z); Mass error (Dppm); Voltage (V); 2-hydroxyestrone (2OHE1); 4-hydroxyestrone (4OHE1);
2-hydroxyestradiol (2OHE2); 4-hydroxyestradiol (4OHE2); 13,14,15,16,17,18-13C6-4-hydroxyestrone (13C6-4OHE1);
13,14,15,16,17,18-13C6-2-hydroxyestradiol (13C6-2OHE2); MPPZ, 1-(2, 4-dinitrophenyl)-4,4-dimethylpiperazine.
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in resolving the catechol estrogen derivative peaks (Fig. 1).
Data illustrated that recovery of catechol estrogens (pre vs post-spiked PA) from Oasis MCX
cartridges, Table 2 was acceptable (2OHE1 73%, 4OHE1 66%, 2OHE2 68% & 4OHE 64%). However, un-
fortunately signiﬁcant ion suppression (unextracted peak area vs extractedþ derivatized estrogenpeak
area) was present for all catechol metabolites recovered from plasma (2OHE1 by 94%, 4OHE1 96.1%,
2OHE2 94.7% & 4OHE2 96.5%), Table 2. Additional clean up steps utilizing aqueous methanol or
acetonitrile (0e70% v/v) improved ion suppression but not to an acceptable degree; the least ion
suppression was observed with washes of 60%v/v MeOH (Ion suppression: 2OHE1 by 80.5%, 4OHE1
78.9%, 2OHE2 79.9% & 4OHE2 79.7%) and 30% ACN (2OHE1 by 80%, 4OHE1 88%, 2OHE2 77% & 4OHE2
86%). Further modiﬁcation of elution solvent (70e100% v/v MeOH) did not decrease ion suppression
sufﬁciently with the optimal wash of 95% v/v MeOH still showing suppression of ~80% (2OHE1 85%,
4OHE1 95%, 2OHE2 78% & 4OHE2 71%). Thus, an alternative extraction protocol for use alongside the
modiﬁed MPPZ derivatization protocol for 2, 4 hydroxy estrogens is required.2. Experimental design, materials, and methods
2.1. Materials
2-Hydroxyestrone (2OHE1), 4-hydroxyestrone (4OHE1), 2-hydroxyestradiol (2OHE2), 4-
hydroxyestradiol (4OHE2) were from Steraloids, Inc (Newport, USA). 13,14,15,16,17,18-13C6-4-Table 2
Indices of extraction performance.
Analyte-
MPPZ
Internal
standard
Unextracted
LOD (pg mL1)
Retention
time (s) (min)
MCX®
recovery (%)
Generic
IonSup (%)
Optimized
IonSup (%)
2OHE1 13C6-4OHE1 20 17.38/17.75 72 ± 3 94 ± 6 72 ± 2
4OHE1 13C6-4OHE1 20 17.62/17.90 68 ± 2 94 ± 2 73 ± 4
2OHE2 13C6-2OHE2 20 16.03/17.00 69 ± 2 93 ± 8 69 ± 8
4OHE2 13C6-2OHE2 20 16.58 62 ± 4 95 ± 9 71 ± 6
2-hydroxyestrone (2 OHE1); 4-hydroxyestrone (4 OHE1); 2-hydroxyestradiol (2 OHE2); 4-hydroxyestradiol (4 OHE2);
13,14,15,16,17,18-13C6-4-hydroxyestrone (13C6-4OHE1); 13,14,15,16,17,18-13C6-2-hydroxyestradiol (13C6-2OHE2); MPPZ, 1-(2, 4-
dinitrophenyl)-4,4-dimethylpiperazine; LOD, Limit of detection;min,minutes;MCX,Mixed Cation Exchange; IonSup, IonSuppression.
Fig. 1. Total and extracted ion chromatograms of (A) methylpiperazine (MPPZ) derivatives of catechol estrogens, (B) The estrone
metabolites 2-Hydroxyestrone (2OHE1), 4-Hydroxyestrone (4OHE1), and (C) the estradiol metabolites 2-Hydroxyestradiol
(2OHE2), 4-Hydroxyestradiol (4OHE2) at 1000 pg mL1. Figure illustrating challenges in separating catechol metabolites by mass
transitions and retention time (min).
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CK Isotopes Limited (Leicestershire, UK). N-Diethylaniline was from Acros Organics (Geel, Belgium). All
additional reagents were sourced as speciﬁed in Denver et al. [1].
2.2. Methods
Analysis, including assessment of extraction efﬁciency and ion suppression, was performed
according to the approach described in Denver et al. [1] and modiﬁcations for catechol estrogens
reported below.
2.2.1. Instrumentation
Structures of fragment ions formed from estrogen derivatives were determined by high resolution
MS using a SYNAPT G2Si instrument (Waters Corp, Manchester, UK) ﬁttedwith an ESI source in positive
mode [1]. Method development was performed using a Shimadzu Nexera X2 LC (Shimadzu, Kyoto,
Japan) coupled to a Sciex 6500 þ Mass Spectrometer (Sciex, Warrington, UK) operated in positive
electrospray (ESI).
2.2.2. Chromatographic conditions
Estrogen metabolites were analyzed both individually and in a mixed solution to conﬁrm sepa-
ration. Two Ace Excel 2 C18-PFP column (150 2.1mm, 2 mmþ 20 2.1mm, 2 mm; HiChrom, Reading,
England) were coupled at an oven temperature of 20 C. A gradient solvent system of water: aceto-
nitrile (90:10), containing formic acid (FA; 0.1%, 0.5 mL/min) was diverted to waste for the initial 9
minutes followed by elution for a further 4minutes at 90:10, thenwith a gradient over 3minutes until
ﬁnal conditions of water: acetonitrile (90:10) containing FA (0.1%, 0.5 mL/min) were achieved. In-
jection volume was 30 mL.
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The following protocol was applied for derivatization PPZ stock (10 mL; 1mgmL1), N-diethylaniline
(10 mL) and acetone (70 mL) were added to the catechol estrogen standards and was capped and
incubated (60 C, 1 h). Reagents were reduced to dryness at 40 C under oxygen free nitrogen (OFN).
The dried residue was incubated (40 C, 2 h) with CH3I (100 mL). The mixture was reduced to dryness
under OFN and dissolved in H2O/CH3CN (70:30; 70 mL).
2.2.4. Extraction and optimization
SPE using Oasis® MCX (3 cc/60 mg, Waters, Wilmslow, UK) cartridges was applied under gravity.
Prior to loading the sample, cartridges were conditioned and equilibrated with methanol (2 mL),
followed by water (2 mL). The diluted sample (0.5 mL plasma þ 0.5mL water (or 1 mL water for
standards) þ 200 pg mL1 Internal Standard) was loaded and allowed to pass through the cartridges
and the eluate discarded. The cartridges werewashedwith aqueous FA (2% v/v, 2 mL). A secondwash of
methanol (60% v/v, 2 mL) was applied with the eluate discarded. Steroids were eluted in methanol
(95%; 2 mL). Extracts were reduced to dryness under OFN (40 C) and the residues were derivatized as
above.
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